NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 35 filers reported holding NYMOX PHARMACEUTICAL CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $893 | -44.1% | 4,700 | 0.0% | 0.00% | – |
| Q1 2023 | $1,598 | +5.1% | 4,700 | 0.0% | 0.00% | – |
| Q4 2022 | $1,520 | -24.0% | 4,700 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 4,700 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -71.4% | 4,700 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $7,000 | -58.8% | 4,700 | 0.0% | 0.00% | -66.7% |
| Q2 2020 | $17,000 | +54.5% | 4,700 | 0.0% | 0.00% | +50.0% |
| Q1 2020 | $11,000 | – | 4,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MARATHON CAPITAL MANAGEMENT | 55,000 | $179,000 | 0.09% |
| WEDBUSH SECURITIES INC | 180,945 | $590,000 | 0.09% |
| Brown Advisory Securities, LLC | 28,000 | $91,000 | 0.03% |
| FNY Managed Accounts LLC | 8,000 | $26,080,000 | 0.02% |
| FT Options LLC | 10,000 | $26,000 | 0.02% |
| WEBSTER BANK, N. A. | 40,000 | $130,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 30,907 | $101,000 | 0.01% |
| GOFEN & GLOSSBERG LLC /IL/ | 25,000 | $82,000 | 0.00% |
| NATIONAL PLANNING CORP | 11,000 | $32,000 | 0.00% |
| Virtu KCG Holdings LLC | 24,705 | $81,000 | 0.00% |